Erratum: A novel epigenetic modulating agent sensitizes pancreatic cells to a chemotherapy agent (PLoS ONE (2018) 13:6 (e0199130) DOI: 10.1371/journal.pone.0199130)

Manjusha Thakar; Yue Hu; Michael Morreale; Lane Lerner; Wan Ying Lin; Rupashree Sen; Yi Cai; Enusha Karunasena; Maya Thakar; Soren Saggi; Harold Keer; Nita Ahuja

doi:10.1371/journal.pone.0242974

Erratum: A novel epigenetic modulating agent sensitizes pancreatic cells to a chemotherapy agent (PLoS ONE (2018) 13:6 (e0199130) DOI: 10.1371/journal.pone.0199130)

Manjusha Thakar, Yue Hu, Michael Morreale, Lane Lerner, Wan Ying Lin, Rupashree Sen, Yi Cai, Enusha Karunasena, Maya Thakar, Soren Saggi, Harold Keer, Nita Ahuja

School of Medicine

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

There is information missing from the Competing Interests statement. The correct Competing Interests statement is as follows: N.A. was a consultant for Cepheid, and has licensed a bio-marker for early detection of pancreas cancer to Cepheid (PATENT # 10167513). N.A also has grant funding from Astex Pharmaceuticals (GRANT # 120039). N.A. has served as a consultant to Johnson and Johnson, as an advisor to Celgene, and as a member of the Scientific Advisory Council to the No Stomach for Cancer Foundation. H.K. reviewed the manuscript; he is a scientific contributor and Vice President at Astex Inc. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Original language	English (US)
Article number	e0242974
Journal	PloS one
Volume	15
Issue number	11 November
DOIs	https://doi.org/10.1371/journal.pone.0242974
State	Published - Nov 2020

ASJC Scopus subject areas

General

Access to Document

10.1371/journal.pone.0242974

Cite this

Thakar, M., Hu, Y., Morreale, M., Lerner, L., Ying Lin, W., Sen, R., Cai, Y., Karunasena, E., Thakar, M., Saggi, S., Keer, H., & Ahuja, N. (2020). Erratum: A novel epigenetic modulating agent sensitizes pancreatic cells to a chemotherapy agent (PLoS ONE (2018) 13:6 (e0199130) DOI: 10.1371/journal.pone.0199130). PloS one, 15(11 November), Article e0242974. https://doi.org/10.1371/journal.pone.0242974

Thakar, M, Hu, Y, Morreale, M, Lerner, L, Ying Lin, W, Sen, R, Cai, Y, Karunasena, E, Thakar, M, Saggi, S, Keer, H & Ahuja, N 2020, 'Erratum: A novel epigenetic modulating agent sensitizes pancreatic cells to a chemotherapy agent (PLoS ONE (2018) 13:6 (e0199130) DOI: 10.1371/journal.pone.0199130)', PloS one, vol. 15, no. 11 November, e0242974. https://doi.org/10.1371/journal.pone.0242974

@article{bb0ee6175fd44fe9a285f18c50d491fb,

title = "Erratum: A novel epigenetic modulating agent sensitizes pancreatic cells to a chemotherapy agent (PLoS ONE (2018) 13:6 (e0199130) DOI: 10.1371/journal.pone.0199130)",

abstract = "There is information missing from the Competing Interests statement. The correct Competing Interests statement is as follows: N.A. was a consultant for Cepheid, and has licensed a bio-marker for early detection of pancreas cancer to Cepheid (PATENT # 10167513). N.A also has grant funding from Astex Pharmaceuticals (GRANT # 120039). N.A. has served as a consultant to Johnson and Johnson, as an advisor to Celgene, and as a member of the Scientific Advisory Council to the No Stomach for Cancer Foundation. H.K. reviewed the manuscript; he is a scientific contributor and Vice President at Astex Inc. This does not alter our adherence to PLOS ONE policies on sharing data and materials.",

author = "Manjusha Thakar and Yue Hu and Michael Morreale and Lane Lerner and {Ying Lin}, Wan and Rupashree Sen and Yi Cai and Enusha Karunasena and Maya Thakar and Soren Saggi and Harold Keer and Nita Ahuja",

note = "Publisher Copyright: {\textcopyright} 2020 Thakar et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.",

year = "2020",

month = nov,

doi = "10.1371/journal.pone.0242974",

language = "English (US)",

volume = "15",

journal = "PloS one",

issn = "1932-6203",

publisher = "Public Library of Science",

number = "11 November",

}

TY - JOUR

T1 - Erratum

T2 - A novel epigenetic modulating agent sensitizes pancreatic cells to a chemotherapy agent (PLoS ONE (2018) 13:6 (e0199130) DOI: 10.1371/journal.pone.0199130)

AU - Thakar, Manjusha

AU - Hu, Yue

AU - Morreale, Michael

AU - Lerner, Lane

AU - Ying Lin, Wan

AU - Sen, Rupashree

AU - Cai, Yi

AU - Karunasena, Enusha

AU - Thakar, Maya

AU - Saggi, Soren

AU - Keer, Harold

AU - Ahuja, Nita

N1 - Publisher Copyright: © 2020 Thakar et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

PY - 2020/11

Y1 - 2020/11

N2 - There is information missing from the Competing Interests statement. The correct Competing Interests statement is as follows: N.A. was a consultant for Cepheid, and has licensed a bio-marker for early detection of pancreas cancer to Cepheid (PATENT # 10167513). N.A also has grant funding from Astex Pharmaceuticals (GRANT # 120039). N.A. has served as a consultant to Johnson and Johnson, as an advisor to Celgene, and as a member of the Scientific Advisory Council to the No Stomach for Cancer Foundation. H.K. reviewed the manuscript; he is a scientific contributor and Vice President at Astex Inc. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

AB - There is information missing from the Competing Interests statement. The correct Competing Interests statement is as follows: N.A. was a consultant for Cepheid, and has licensed a bio-marker for early detection of pancreas cancer to Cepheid (PATENT # 10167513). N.A also has grant funding from Astex Pharmaceuticals (GRANT # 120039). N.A. has served as a consultant to Johnson and Johnson, as an advisor to Celgene, and as a member of the Scientific Advisory Council to the No Stomach for Cancer Foundation. H.K. reviewed the manuscript; he is a scientific contributor and Vice President at Astex Inc. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

UR - http://www.scopus.com/inward/record.url?scp=85096814155&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85096814155&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0242974

DO - 10.1371/journal.pone.0242974

M3 - Comment/debate

C2 - 33216806

AN - SCOPUS:85096814155

SN - 1932-6203

VL - 15

JO - PloS one

JF - PloS one

IS - 11 November

M1 - e0242974

ER -

Erratum: A novel epigenetic modulating agent sensitizes pancreatic cells to a chemotherapy agent (PLoS ONE (2018) 13:6 (e0199130) DOI: 10.1371/journal.pone.0199130)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this